For people who received a mesothelioma diagnosis in recent years, making new year’s resolutions can seem like a futile thing to do. But mental health experts say healthy resolutions can help us focus on the future and stay positive. Positive mesothelioma patients may experience less pain and enjoy a higher quality of life. In light of that, here are five new year’s resolutions for mesothelioma patients to consider. New Year’s Resolution #1 – Look for clinical trials There is no cure for malignant mesothelioma. Even the best standard treatments, including chemotherapy and radiotherapy, are often only minimally effective. One of the best ways for mesothelioma patients to connect with new and emerging treatments is to participate in a mesothelioma clinical … Continue reading Five New Year’s Resolutions All Mesothelioma Patients Should Make
A newly-published report suggests that artificial intelligence (AI) might help pathologists predict recurrence of mesothelioma. The report focuses on technology developed by the RIKEN Center for Advanced Intelligence Project (AIP) in Japan. The Center claims the computer program taught itself to recognize key features in images of cancer. Some of the features were ones that even pathologists did not know about. The findings suggest that AI and pathologists could predict recurrence of mesothelioma better than pathologists alone. How AI Might Predict Recurrence of Mesothelioma A computer program usually has to be “taught” to perform a certain task. But this limits how far the learning can go. Instead of “teaching” it about cancer, researchers let the RIKEN technology learn on its … Continue reading It May Be Possible to Predict Recurrence of Mesothelioma with Help from AI
An international team of scientists has identified a protein biomarker for mesothelioma that appears to shorten survival. The biomarker is CD70. It belongs to the tumor necrosis factor (TNF) family of proteins. New research suggests that patients who express more of this protein biomarker for mesothelioma have faster-growing tumors that are less likely to respond to treatment. High CD70 levels have been linked with tumor aggression in some other types of cancer. This is the first time they have been linked to malignant pleural mesothelioma survival. CD70 and Mesothelioma Prognosis Pleural mesothelioma is a highly aggressive type of tumor. It grows on the membranes around internal organs. Mesothelioma rarely responds to standard cancer treatments. People diagnosed with pleural mesothelioma are … Continue reading Protein Biomarker for Mesothelioma Linked to Shorter Survival
A new study suggests that it could be risky to take supplements during chemotherapy for mesothelioma and other cancers. The study took place at the Roswell Park Comprehensive Cancer Center in Buffalo, New York. It focused on more than 1,100 breast cancer patients. It found that patients who took certain antioxidant supplements during chemotherapy had worse outcomes than those who did not. The study’s authors say antioxidants undermine one of the main jobs of chemotherapy drugs – to create oxidative stress in cancer cells. Chemotherapy is the primary first-line treatment for malignant mesothelioma and many other cancers. Why Avoid Antioxidant Supplements During Chemotherapy? Antioxidants are compounds found in many fruits and vegetables. Vitamins A, C, E, and B12 are examples … Continue reading Supplements During Chemotherapy May Work Against Mesothelioma Treatment
Researchers in Switzerland say a pesticide designed to make grapes and kiwifruit bigger can also slow mesothelioma cell growth. The EPA approved forchlorfenuron (FCF) in 2004. Farmers use it to help grapes and kiwifruit grow bigger, break less easily, and last longer in cold storage. But new research at the University of Fribourg suggests that the chemical has the opposite effect on mesothelioma cell growth. Mesothelioma cells exposed to FCF are less likely to live and spread. The researchers say this could be a promising step toward a new kind of mesothelioma treatment. Forchlorfenuron and Mesothelioma Cell Growth The EPA classifies FCF as a plant growth regulator. According to the EPA fact sheet, FCF is a cytokinin which “improves fruit … Continue reading Pesticide Inhibits Mesothelioma Cell Growth in Lab Animals
A temporary increase in pain may be a sign of success when undergoing pleurodesis for mesothelioma-related lung fluid. An uncomfortable build-up of lung fluid is one of the most common and life-limiting mesothelioma symptoms. Chemical pleurodesis is one way doctors treat the problem. About three out of four patients have good luck with pleurodesis for mesothelioma. Now, a new study from the UK suggests that those who have the best results with the procedure also tend to have the most pain afterward. What is Pleurodesis for Mesothelioma? Pleural mesothelioma is a malignancy that starts in the layers of the pleura. The pleura is a membrane that surrounds the lungs. When tumors grow in the pleural membrane, they can trigger a … Continue reading Pain a Sign of Successful Pleurodesis for Mesothelioma, Study Says
A common antibiotic may improve mesothelioma patients’ response to radiation therapy. The concept is based on new research from the Perelman School of Medicine at the University of Pennsylvania. Doctors there gave the antibiotic vancomycin to genetically modified mice. The mice had been modified to develop cancer. Mice that got the antibiotic had a better response to radiation therapy than untreated mice. The effect applied not only to the treated tumor but also to tumors outside the treatment area. A heightened response to radiation therapy could be good news for patients with metastatic mesothelioma. Understanding Cancer Response to Radiation Therapy Radiation therapy combats malignant mesothelioma by disrupting the DNA inside cancer cells. Mesothelioma tumors are irregularly-shaped which can make them … Continue reading Antibiotic May Boost Response to Radiation Therapy for Mesothelioma
FDG-PET/CT may be a more effective way to track malignant pleural mesothelioma recurrence than contrast-enhanced CT scanning. That is the conclusion of cancer researchers with Japan’s Hyogo College of Medicine. The researchers focused on fifty patients who underwent radical surgery for pleural mesothelioma. Afterwards, doctors used both FDG-PET/CT and contrast-enhanced CT scans to track mesothelioma progression. Two experienced examiners assessed the cases. They concluded that FDG-PET/CT was more accurate than CT for diagnosing mesothelioma recurrence. Mesothelioma Recurrence After Surgery Pleural mesothelioma is one of the most difficult cancers to treat. It arises in the layers of the pleural membrane that surrounds the lungs. Mesothelioma tumors tend to grow and spread quickly. Treatments like chemotherapy, surgery, and radiotherapy can sometimes slow … Continue reading Tracking Mesothelioma Recurrence: FDG-PET/CT Versus CT
The findings of a major new study on cancer and alcohol suggest there may be an even stronger link between drinking and mesothelioma risk than previously thought. The Japanese study included more than 120,000 drinkers and non-drinkers. It tracked which participants got any type of cancer over a 15 year period. Cancer diagnoses were correlated with participants’ drinking habits. The report found that even light drinkers faced a higher incidence of cancers like malignant mesothelioma. It is one of the largest studies to connect cancer incidence, drinking and mesothelioma risk. Even Light to Moderate Drinkers Face Risk Scientists have known about the connection between drinking and mesothelioma risk for some time. But the problem of alcohol consumption and cancer had … Continue reading Drinking and Mesothelioma Risk: How Much is Too Much?
Newly diagnosed pleural mesothelioma patients may be at higher risk for depression and that could be impacting their outcomes. A new report finds that people diagnosed with advanced lung cancers are more likely to suffer from depression. Pleural mesothelioma is a form of lung cancer. This risk for depression appears to have an impact on patients’ quality of life, their pain, and even the number of complications they experience. Assessing the Risk for Depression in Cancer Patients Researchers at Ohio State University directed the study. It included 186 patients with Stage IV non-small-cell lung cancer. The patients had not yet started their cancer treatment. Although pleural mesothelioma is not the same as non-small cell lung cancer, the two diseases share … Continue reading Is There a Risk for Depression Among Pleural Mesothelioma Patients?